Oleptiss 360mg Tablet DT
Marketer
Novartis India Ltd
Salt Composition
Deferasirox (360mg)
Overview Oleptiss 360mg Tablet DT
Deferoxamine 360mg extended-release tablets treat chronic iron buildup from repeated blood transfusions. This medication facilitates iron excretion, mitigating potential organ damage. Administer Deferoxamine 360mg extended-release tablets on an empty stomach, adhering strictly to the prescribed dosage and schedule for optimal efficacy. Common side effects may include nausea, headache, constipation, or diarrhea. Report persistent or worsening side effects to your physician immediately. Prior to commencing treatment, disclose any pre-existing kidney or liver conditions, and provide a comprehensive list of all current medications to ensure safe usage.
Primary Ingredients of Oleptiss 360mg Tablet DT
No text was provided. Please provide the text you wish me to rephrase.
Uses of Oleptiss 360mg Tablet DT
Managing excess iron in the body
Major Benefits of Oleptiss 360mg Tablet DT:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Oleptiss 360mg Tablet DT in water before consumption. Administer on an empty stomach.
Common Side effects of Oleptiss 360mg Tablet DT:
- Nausea
- Headache
- Vomiting
- Rash
- Abdominal pain
- Constipation
- Itching
- Abdominal distension
- Diarrhea
How to use Oleptiss 360mg Tablet DT:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Dissolve the Oleptiss 360mg Tablet DT in water before ingestion. It should be taken on an empty stomach.
How Oleptiss 360mg Tablet DT works:
Oleptiss 360mg Delayed-Release Tablets bind and eliminate surplus iron, primarily through fecal excretion, thereby mitigating the potential for organ injury.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Oleptiss 360mg Tablet DT may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Oleptiss 360mg Tablet DT during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in exceptional, life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Based on available data, the use of Oleptiss 360mg DT tablets while breastfeeding appears to pose minimal risk to the infant. Studies in humans indicate negligible adverse effects on the nursing child.
DrivingUNSAFE
Taking Oleptiss 360mg Delayed-Release Tablets might cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving should be avoided if these effects are experienced.
KidneyUNSAFE
The use of Oleptiss 360mg Tablet DT is likely inadvisable for individuals with kidney impairment and should be omitted. Seek medical advice.
LiverCAUTION
Patients with hepatic impairment should use Oleptiss 360mg Tablet DT cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Oleptiss 360mg Tablet DT :
Should you forget to take your Oleptiss 360mg Tablet DT, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Oleptiss 360mg Tablet DT
| Label | Value |
|---|---|
| Chemical Category | Benzoate-triazole hybrid |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
3,018 People bought this recently